Vitrafy Life Sciences Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Public

  • Employees
  • 19

Employees

  • Stock Symbol
  • VFY

Stock Symbol

  • Share Price
  • $1.60
  • (As of Thursday Closing)

Vitrafy Life Sciences General Information

Description

Vitrafy Life Sciences Ltd is the research, development and commercialisation of its integrated cryopreservation solution. This includes cryopreservation medical devices (freezer, thawer and packaging solutions), Life Chain integrated software system, and services for application areas in human health and animal reproduction. The group has one operating segment. The company's solutions are LifeChain TM, and Guardion TM. LifeChain TM is the nexus of modern cryopreservation, an intelligent platform unifying data-driven optimization, world-wide logistics, and proprietary algorithms to create bespoke freeze curves. Guardion TM rapidly freezes T-cells in under four minutes while maintaining post-thaw quality rivaling fresh controls.

Contact Information

Website
www.vitrafy.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 80 Technology Drive
  • Irvine, CA 92618
  • United States
Primary Industry
Other Devices and Supplies
Other Industries
Biotechnology
Other Healthcare Technology Systems
Stock Exchange
ASX
Vertical(s)
Corporate Office
  • 80 Technology Drive
  • Irvine, CA 92618
  • United States

Vitrafy Life Sciences Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vitrafy Life Sciences Stock Performance

As of 19-Nov-2026, Vitrafy Life Sciences’s stock price is $1.60. Its current market cap is $122M with 76.2M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.60 $1.65 $0.85 - $3.30 $122M 76.2M 69.6K

Vitrafy Life Sciences Financials Summary

As of 30-Sep-2026, Vitrafy Life Sciences has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 30-Sep-2026 FY 2026 30-Jun-2026 FY 2025 30-Jun-2025 FY 2024 30-Jun-2024
EV 184,561 140,713 40,340
Revenue 114 42 24
EBITDA (11,396) (17,416) 5
Net Income (10,955) (21,164) (6,832)
Total Assets 29,738 20,800 27,626
Total Debt 208 256 317
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Vitrafy Life Sciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Vitrafy Life Sciences‘s full profile, request access.

Request a free trial

Vitrafy Life Sciences Patents

Vitrafy Life Sciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023902850-A0 Method and system for controlling the processing of biological materials Inactive 05-Sep-2023
AU-2024219387-A1 Method and system for controlling the processing of biological materials Pending 05-Sep-2023
EP-4774731-A1 Method and system for controlling the processing of biological materials Pending 05-Sep-2023
JP-2026533148-A Method and system for controlling the processing of biological materials Pending 05-Sep-2023
WO-2025050165-A1 Method and system for controlling the processing of biological materials Inactive 05-Sep-2023 G16B40/20
To view Vitrafy Life Sciences’s complete patent history, request access »

Vitrafy Life Sciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vitrafy Life Sciences ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Medical Devices

Subindustry

Rank

Percentile

To view Vitrafy Life Sciences’s complete esg history, request access »

Vitrafy Life Sciences FAQs

  • When was Vitrafy Life Sciences founded?

    Vitrafy Life Sciences was founded in 2017.

  • Where is Vitrafy Life Sciences headquartered?

    Vitrafy Life Sciences is headquartered in Irvine, CA.

  • What is the size of Vitrafy Life Sciences?

    Vitrafy Life Sciences has 19 total employees.

  • What industry is Vitrafy Life Sciences in?

    Vitrafy Life Sciences’s primary industry is Other Devices and Supplies.

  • Is Vitrafy Life Sciences a private or public company?

    Vitrafy Life Sciences is a Public company.

  • What is Vitrafy Life Sciences’s stock symbol?

    The ticker symbol for Vitrafy Life Sciences is VFY.

  • What is the current stock price of Vitrafy Life Sciences?

    As of 19-Nov-2026 the stock price of Vitrafy Life Sciences is $1.60.

  • What is the current market cap of Vitrafy Life Sciences?

    The current market capitalization of Vitrafy Life Sciences is $122M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process